Tag Archives: patients

FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia

Print this page HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of Imbruvica (ibrutinib) in combination with obinutuzumab in treatment-naïve patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), the most common form of leukemia in adults.1 This is… Read More »

SickKids study finds blood tests alone may be effective strategy for detecting cancer relapse in certain patients

For most cancer patients, medical tests and examinations don’t end with the completion of therapy, even if their cancer has gone into remission. They will be due for several follow-up appointments, which can include blood tests, imaging tests and other exams as part of a surveillance protocol to detect possible relapse. One of the regular… Read More »